Junevity
PrivateLast Round
Seed
Dec 4, 2025
Total Funding Raised
$20M
Company Overview
Junevity is a biotechnology company that develops cell reset therapeutics for longevity by using large-scale human data and AI to identify transcription factor targets and repress them with siRNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Junevity Comps
Public and private peers based on sector, stage, and business model.
Junevity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 4, 2025 | ||||
| Seed | Feb 13, 2025 |
Junevity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Goldcrest Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2025
$10M raised in Seed round.
- Feb 13, 2025
Developing "cell reset" therapies to extend healthspan and lifespan.
Junevity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Junevity's valuation, stock price, and market status.
